Homoarginine deficiency is associated with increased bone turnover

Osteoporosis International

Volumn 23, Issue 11, 2012, Pages 2731-2732

  Pilz, S ^a,b   Meinitzer, A ^a   Tomaschitz, A ^a   Kienreich, K ^a   Fahrleitner Pammer, A ^a   Drechsler, C ^c   Boehm, B O ^d   Marz W ^a,e,f  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY OF ULM   (Germany)

^e SYNLAB ACADEMY   (Germany)

^f UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CYSTATIN C; HOMOARGININE; NITRIC OXIDE; OSTEOCALCIN; PARATHYROID HORMONE;

BODY MASS; BONE METABOLISM; BONE TURNOVER; CARDIOVASCULAR RISK; ENERGY METABOLISM; HUMAN; LETTER; OSSIFICATION; PRIORITY JOURNAL;

ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE REMODELING; COLLAGEN; FEMALE; HOMOARGININE; HUMANS; MALE; OSTEOCALCIN; PEPTIDE FRAGMENTS;

EID: 84868210624     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-012-1904-2     Document Type: Letter

References (11)

1. Meinitzer A, Drechsler C, Tomaschitz A, Pilz S, Krane V, Wanner C, März W (2011) Homoarginine: a new cardiovascular risk marker in hemodialysis patients. J Lab Med 35(3):153-159
2. Wallimann T, Tokarska-Schlattner M, Schlattner U (2011) The creatine kinase system and pleiotropic effects of creatine. Amino Acids 40(5):1271-1296
3. Kozlenkov A, Le Du MH, Cuniasse P, Ny T, Hoylaerts MF, Millán JL (2004) Residues determining the binding specificity of uncompetitive inhibitors to tissue-nonspecific alkaline phosphatase. J Bone Miner Res 19(11):1862-1872
4. Valtonen P, Laitinen T, Lyyra-Laitinen T, Raitakari OT, Juonala M, Viikari JS, Heiskanen N, Vanninen E, Punnonen K, Heinonen S (2008) Serum L-homoarginine concentration is elevated during normal pregnancy and is related to flow-mediated vasodilatation. Circ J 72(11):1879-1884
5. Wimalawansa SJ (2010) Nitric oxide and bone. Ann N YAcad Sci 1192:391-403
6. März W, Meinitzer A, Drechsler C, Pilz S, Krane V, Kleber ME, Fischer J, Winkelmann BR, Böhm BO, Ritz E, Wanner C (2010) Homoarginine, cardiovascular risk, and mortality. Circulation 122 (10):967-975
7. Pilz S, Tomaschitz A, Meinitzer A, Drechsler C, Ritz E, Krane V, Wanner C, Böhm BO, März W (2011) Low serum homoarginine is a novel risk factor for fatal strokes in patients undergoing coronary angiography. Stroke 42(4):1132-1134
8. Pilz S, Meinitzer A, Tomaschitz A, Drechsler C, Ritz E, Krane V, Wanner C, Boehm BO, März W (2011) Low homoarginine concentration is a novel risk factor for heart disease. Heart 97 (15):1222-1227
9. Drechsler C, Meinitzer A, Pilz S, Krane V, Tomaschitz A, Ritz E, März W, Wanner C (2011) Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients. Eur J Heart Fail 13(8):852-859
10. Rao SL (2011) A look at the brighter facets of β-N-oxalyl-l-α, β-diaminopropionic acid, homoarginine and the grass pea. Food Chem Toxicol 49(3):620-622
11. Cullen ME, Yuen AH, Felkin LE, Smolenski RT, Hall JL, Grindle S, Miller LW, Birks EJ, Yacoub MH, Barton PJ (2006) Myocardial expression of the arginine: glycine amidinotrans-ferase gene is elevated in heart failure and normalized after recovery: potential implications for local creatine synthesis. Circulation 114(1 Suppl):16-20